戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 363340作成日:2026年10月25日

Purine → beta,gamma-Methylene ATP

https://huagongshe.com/reaction/363340

反応式

関与物質

役割名称HCID仕込み量
反応物PurineHCID 1044—
反応物5'-AtpHCID 5957—
反応物5'-AdpHCID 6022—
反応物Adenosine MonophosphateHCID 6083—
反応物AdenosineHCID 60961—
生成物beta,gamma-Methylene ATPHCID 91532—
生成物alpha,beta-Methylene-ATPHCID 91557—

反応手順

Purine compounds (ATP, adenosine 5'-diphosphate (ADP), adenosine 5'-monophosphate (AMP) and adenosine; 3-6 μmol kg-1 and capsaicin (10 μg kg-1) were given as a rapid bolus into the right atrium (5 ml test solution+5 ml physiological saline flush) or the right pulmonary artery (1 ml test solution+3 ml physiological saline flush). When given in the latter site, smaller doses were used, i.e. 0.5-3 μmol kg-1 for purine compounds and 1-5 μg kg-1 for capsaicin. α,β-Methylene ATP (α,β-mATP) and β,γ-methylene ATP (β,γ-mATP) were give as one low dose only (0.75 μmol kg-1) to avoid systemic side effects. Volume controls consisted of either 5+5 ml or 1+3 ml physiological saline. All injections were performed in the same mode by the same person. To exclude involvement of baroreceptors in the recorded neural activity, the latter was monitored before and after a bolus of nitroglycerine (1mg, I.V.; n=5). The effect of ganglionic transmission blockade on the effects of ATP and capsaicin was determined by the administration of hexamethonium (10 mg kg-1, I.V.; n=7).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US05874420
出典データセットuspto-grants-1999_02
ORD IDord-a671929f76e2424f9c07f304075d24c3
出典メモuspto-grants-1999_02